The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Evidence · Study critique

A structured critique template this community uses — a second dataset

Solved
Solved by f.laurent in post #2
Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished negative trials is a fair critical question.

Jump to the accepted answer →

PR
policy_readerTL2Regular30 May 2026#1

On the subject in the title: A structured critique template this community uses — a second dataset Working notes rather than a conclusion.

Session topic: SELECT (N Engl J Med, 2023). Please read it before posting; the discussion is much better when everyone has.

The question I would like us to start with is what the trial set out to estimate, rather than what it found. Once that is on the table we can talk about whether the design could have answered it, and only then about the numbers.

Specific things I would like covered: the population and how far it generalises, how discontinuation was handled, whether the comparator was a fair one, and what the absolute rather than relative effect looks like.

I will summarise at the end and the summary will feed the relevant digest page.

54 likes 2mo
FL
f.laurentTL2 Moderator Solution2 Jun 2026#2

Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished negative trials is a fair critical question.

7 likes 2mo
KB
k.bettencourtTL2Member4 Jun 2026#3

Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence.

3 likes 2mo
AC
a.coelhoTL2 Moderator5 Jun 2026#4
f.laurent, post #2: Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished negative trials is a fair critical question. Go to post

Worth separating two things that post #3 runs together.

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

10 likes in reply to #2 2mo
AW
a.westergaardTL3Regular7 Jun 2026#5

Picking up post #2: that is the part I would want checked first.

Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown confounders, though known confounders can be adjusted for.

0 likes 2mo
DY
d.yilmazTL2 Moderator8 Jun 2026#6

Coming back to post #4, because the follow-up matters more than the original answer.

Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism but requires specificity about which real people and why the difference matters.

0 likes 2mo
SE
septum_entryTL2Member10 Jun 2026 · edited#7
policy_reader, post #1: On the subject in the title: A structured critique template this community uses — a second dataset Working notes rather than a conclusion. Session topic: SELECT ( N Engl J Med , 2023). Please read it before posting; the discussion is much better when everyone has. The question I would like us to start with is what the trial set out to… Go to post

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

5 likes in reply to #1 2mo
CF
c.falkTL2 Moderator11 Jun 2026#8
k.bettencourt, post #3: Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence. Go to post

Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question. Sometimes that is what the sponsor wanted, sometimes the researchers did the best they could with constraints.

15 likes in reply to #3 2mo
CL
c.lundgrenTL213 Jun 2026#9
NN
n.nybergTL2 Moderator14 Jun 2026#10

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

31 likes 1mo
DW
diluent_watchTL2Member15 Jun 2026#11

When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you originally thought. That is not a failure — it is how discussion works.

0 likes 1mo
DN
d.ndiayeTL2 Moderator17 Jun 2026 · edited#12

Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either way, the exchange in public is more useful than quiet disagreement.

0 likes 1mo
Z
ZieglerTL3Regular18 Jun 2026#13
d.yilmaz, post #6: Coming back to post #4, because the follow-up matters more than the original answer. Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism but requires specificity about which real people and why the difference matters. Go to post

I read post #11 twice before replying, because I had assumed the opposite.

What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample size" alone is weak. "Small sample size for a rare outcome, so the confidence interval is wide" is stronger.

14 likes in reply to #6 1mo
MD
m.dumitruTL2 Moderator19 Jun 2026#14
a.coelho, post #4: Worth separating two things that post #3 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had been repeating something I had not checked carefully enough. Go to post

This follows post #11 rather than contradicting it.

Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is more idiosyncratic. That does not make it wrong but it is worth noticing.

5 likes in reply to #4 1mo
RS
r.scholtenTL2Member20 Jun 2026#15

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

0 likes 1mo
GV
g.verhoevenTL2 Moderator21 Jun 2026#16

post #15 answers the question as asked. The question underneath it is different.

Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not how you use the evidence. The point estimate and the precision both matter.

28 likes 1mo
MS
m.stephanopoulosTL3Regular23 Jun 2026#17

Coming back to post #15, because the follow-up matters more than the original answer.

Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null.

9 likes 1mo
BN
b.nwosuTL2 Moderator24 Jun 2026#18
septum_entry, post #7: Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up. Go to post

Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence.

2 likes in reply to #7 1mo
R
RidgewayTL3Regular25 Jun 2026 · edited#19

Worth separating two things that post #15 runs together.

Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is more idiosyncratic. That does not make it wrong but it is worth noticing.

0 likes 1mo
IG
i.grimaldiTL2 Moderator26 Jun 2026#20

post #19 is right about the mechanism and I think understates the practical bit.

Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question. Sometimes that is what the sponsor wanted, sometimes the researchers did the best they could with constraints.

21 likes 1mo
HR
h.ramosTL2 Moderator27 Jun 2026#21

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

4 likes 1mo
C
CSagredoTL3Regular28 Jun 2026#22

What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample size" alone is weak. "Small sample size for a rare outcome, so the confidence interval is wide" is stronger.

12 likes 30d
RM
r.molnarTL229 Jun 2026#23
CI
c.inglethorpeTL3Regular30 Jun 2026#24
n.nyberg, post #10: Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive. Go to post

When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you originally thought. That is not a failure — it is how discussion works.

0 likes in reply to #10 28d
FC
f.chowdhuryTL2 Moderator1 Jul 2026#25

Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism but requires specificity about which real people and why the difference matters.

7 likes 27d
T
ThibodeauTL3Regular2 Jul 2026#26

Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished negative trials is a fair critical question.

18 likes 26d
HA
h.amankwahTL2 Moderator3 Jul 2026#27

This follows post #24 rather than contradicting it.

Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown confounders, though known confounders can be adjusted for.

0 likes 24d
ME
m.eriksenTL2 Moderator4 Jul 2026#28
c.lundgren, post #9: Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null. Go to post

I read post #26 twice before replying, because I had assumed the opposite.

Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null.

0 likes in reply to #9 23d
ME
m.ekstromTL2 Moderator5 Jul 2026#29
r.scholten, post #15: Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound. Go to post

post #28 answers the question as asked. The question underneath it is different.

Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown confounders, though known confounders can be adjusted for.

0 likes in reply to #15 22d
LP
l.piresTL2 Moderator6 Jul 2026#30

On post #26 — agreed on the reasoning, with one qualification.

Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism but requires specificity about which real people and why the difference matters.

4 likes 21d